| | | | | WASHINGTON (Reuters) -The U.S. House of Representatives on Monday began debate on a $900 billion coronavirus aid package meant to stimulate a pandemic-hit economy, which the leaders of both chambers of Congress aimed to pass in a marathon session. | | | U.S. President-elect Joe Biden received his first injected dose of the COVID-19 vaccine live on television on Monday in an effort to boost confidence in its safety ahead of its wide distribution next year. | | | NEW YORK (Reuters) -A gauge of equities around the world fell on Monday and oil prices plunged as concerns about a new coronavirus strain in Britain overshadowed optimism over a vaccine-fueled rebound in economic growth. | | | U.S. President-elect Joe Biden received his first dose of the Pfizer Inc COVID-19 vaccine on Monday at a hospital in Newark, Delaware, and he urged Americans to get the vaccine when it is available. | | | The Trump administration on Monday published a list of Chinese and Russian companies with alleged military ties that restrict them from buying a wide range of U.S. goods and technology. | | | NEW YORK (Reuters) -The S&P 500 closed lower on Monday, having clawed its way back from steep losses early in the session as investors juggled the outbreak of an ominous new strain of COVID-19 with the passage of a long-anticipated stimulus package. | | | Apple Inc is moving forward with self-driving car technology and is targeting 2024 to produce a passenger vehicle that could include its own breakthrough battery technology, people familiar with the matter told Reuters. | | | NEW YORK (Reuters) -Oil prices tumbled nearly 3% on Monday as a fast-spreading new coronavirus strain that has shut down much of Britain and led to tighter restrictions in Europe sparked worries about a slower recovery in fuel demand. | | | Total investor inflows into cryptocurrency funds and products hit $5.6 billion so far this year, up more than 600% from 2019, according to the latest data from asset manager CoinShares. | | | The European Union geared up to start mass vaccinations against COVID-19 just after Christmas after the shot developed by Pfizer and its German partner BioNTech cleared regulatory hurdles on Monday. | | | | | | | | | |